Redwood Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,456
Closed -$877K 16
2026
Q1
$877K Sell
14,456
-214
-1% -$12.5K 0.38% 58
2025
Q4
$791K Buy
14,670
+1,150
+9% +$55.3K 0.33% 62
2025
Q3
$610K Sell
13,520
-532
-4% -$24.8K 0.26% 80
2025
Q2
$650K Buy
14,052
+101
+0.7% +$4.96K 0.29% 72
2025
Q1
$851K Buy
13,951
+688
+5% +$40.1K 0.43% 55
2024
Q4
$749K Buy
13,263
+197
+2% +$11K 0.37% 62
2024
Q3
$676K Buy
13,066
+242
+2% +$11.4K 0.34% 65
2024
Q2
$533K Buy
12,824
+73
+0.6% +$3.27K 0.4% 52
2024
Q1
$691K Buy
12,751
+123
+1% +$6.27K 0.73% 35
2023
Q4
$648K Buy
12,628
+2,247
+22% +$118K 0.72% 36
2023
Q3
$603K Sell
10,381
-1,135
-10% -$69.5K 0.7% 40
2023
Q2
$736K Sell
11,516
-481
-4% -$32.3K 0.82% 33
2023
Q1
$832K Buy
11,997
+18
+0.2% +$1.27K 0.94% 25
2022
Q4
$862K Buy
+11,979
New +$903K 1.08% 24

Other funds holding BMY

Redwood Wealth Management Group's BMY Position: Q2 2026 in Review

Redwood Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 14,456 shares — an estimated $877K sold.

Redwood Wealth Management Group first reported a position in BMY in Q4 2022 and held it in 14 quarters. The position peaked at $877K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Redwood Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Redwood Wealth Management Group sold 14,456 Bristol-Myers Squibb shares in Q2 2026, an estimated $877K.
  • Redwood Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 14 quarters.
  • Redwood Wealth Management Group's Bristol-Myers Squibb position peaked at $877K in Q1 2026.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Redwood Wealth Management Group's 13F filing for Q2 2026.